REGENXBIO Inc.
RGNX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001590877
In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 2 sales; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.
Members of Congress who traded RGNX
No member of Congress has reported a trade in REGENXBIO Inc. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.